Tuesday, January 04, 2022 8:26:50 AM
ADVM
Recent ADVM News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/17/2024 10:11:11 PM
- Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/06/2024 09:05:00 PM
- Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/20/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 09:05:45 PM
- Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements • GlobeNewswire Inc. • 11/18/2024 12:00:00 PM
- Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements • GlobeNewswire Inc. • 11/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:57:12 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:40:56 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:05:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 07:17:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:44:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:42:51 PM
- Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones • GlobeNewswire Inc. • 11/04/2024 09:39:45 PM
- Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:24 PM
- Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:10:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:00 PM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S. • AVAI • Dec 17, 2024 8:00 AM
North Bay Resources Announces MET Results of 97% Gold Recovery with Upgrade to 11.2 Ounces per Ton Concentrate, Fran Gold Project; Completes 120 Ton Winter Ore Shipment • NBRI • Dec 16, 2024 9:00 AM
Mass Megawatts Announces the Financial Reporting Status Being Current as of Today • MMMW • Dec 16, 2024 8:18 AM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM